Vepdegestrant
Source: THSubject: Science and technology Context: The U.S. Food and Drug Administration (FDA) has approved vepdegestrant, marking a historic milestone as the world’s first-ever approved therapy based on PROTAC (Proteolysis-Targeting Chimera) technology. Vepdegestrant About Vepdegestrant: What It Is? Vepdegestrant is a first-in-class, orally administered therapeutic molecule designed using PROTAC technology. Instead of merely blocking a …
